Integrating differentially expressed genes (DEGs; tumor vs. normal tissue), DFS-associated prognostic genes from multiple cohorts (Figure S1E-F), and hub genes from the magenta module, we identified PXDN as a key regulator (Fig. 1B). This evidence concerns the gene PXDN and neoplasm.